Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Oxcarbazepine (150mg) Tablet
Therapeutic Category
Neurology, Antiepileptic
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹129/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Oxcelzine 150 Tablet contains Oxcarbazepine 150 mg, an anticonvulsant medicine used to manage and prevent epileptic seizures and focal onset seizures in adults and children. It works by stabilizing neuronal membranes and reducing excessive electrical signals in the brain that trigger seizures.
Oxcarbazepine belongs to the neurology and CNS therapy segment and is commonly prescribed by neurologists and general physicians for long-term seizure control. It offers improved tolerability compared to older antiepileptic drugs, making it suitable for chronic management and combination therapy.
Due to its consistent clinical demand, Oxcelzine 150 remains a highly profitable product for PCD pharma franchise partners, wholesalers, and institutional suppliers. It is also available for bulk distribution, export, and third-party manufacturing with competitive business margins.
Dizziness, drowsiness, nausea, headache, fatigue, blurred vision, imbalance, vomiting, or tremors. In rare cases, it may cause low sodium levels, mood changes, or skin reactions.
Used in the treatment of partial seizures, generalized tonic-clonic seizures, and epilepsy. It may also be prescribed as adjunct therapy in patients who do not respond adequately to other antiepileptic drugs.
Take Oxcelzine 150 Tablet exactly as advised. Do not stop suddenly as it may worsen seizures. Inform your doctor if pregnant, planning pregnancy, breastfeeding, or taking other seizure medicines. Avoid driving or operating machinery until effects are known.
Store below 25°C in a cool, dry place away from sunlight and moisture. Keep out of reach of children.
Composition : Etodolac (600mg)
Composition : Etoricoxib (60mg) Tablet
Composition : Etoricoxib (90mg) Tablet
Composition : Etoricoxib (60mg) + Paracetamol (325mg)
Composition : Nimesulide (100mg) MD Tablet
Composition : Piroxicam (20mg) Tablet
Composition : Etoricoxib (60mg) + Thiocolchicoside (4mg)
Composition : Diclofenac (50mg) + Paracetamol (325mg) + Serratiopeptidase (10mg)
Composition : Diclofenac (50mg) + Serratiopeptidase (10mg)
Composition : Diclofenac (50mg) + Paracetamol (325mg) + Trypsin Chymotrypsin (50000AU)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Oxcarbazepine IP 150mg Tablet has strong demand in the neurology, epilepsy care, and CNS (Central Nervous System) segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on neurological and specialty medicine portfolios.
Medical distributors and agencies can benefit from demand for seizure disorder management under specialist supervision. Oxcarbazepine IP 150mg is an antiepileptic (anticonvulsant) medication used in neurological care Commonly prescribed for the management of partial seizures (focal seizures) and epilepsy as advised by healthcare professionals Helps stabilize abnormal electrical activity in the brain, supporting effective seizure control in appropriate patients Lower-strength formulation provides flexibility for treatment initiation, dose titration, and individualized therapy plans Oral tablet formulation offers convenient administration for long-term treatment under medical supervision Requires regular monitoring and dosage adjustments based on patient response and clinical requirements Frequently utilized in neurology clinics, epilepsy centers, hospitals, and specialty healthcare facilities Widely prescribed by neurologists and CNS specialists This strengthens a comprehensive neurology and epilepsy care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Oxcarbazepine IP 150mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from consistent prescription demand, specialty healthcare market opportunities, repeat purchases, reliable supply chain support, and attractive margins in the neurology segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.